Sabra Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Sabra Healthcare REIT
SBRA Stock  USD 18.84  0.02  0.11%   
Sabra Healthcare's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Sabra Healthcare's valuation are provided below:
Gross Profit
497.8 M
Profit Margin
0.2344
Market Capitalization
4.7 B
Enterprise Value Revenue
9.5372
Revenue
747.1 M
We have found one hundred twenty available fundamental trend indicators for Sabra Healthcare REIT, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Sabra Healthcare REIT current market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. As of January 27, 2026, Market Cap is expected to decline to about 1.6 B. In addition to that, Enterprise Value is expected to decline to about 3.2 B

Sabra Healthcare Total Revenue

429.35 Million

Check Sabra Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sabra Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 134.9 M, Interest Expense of 86.1 M or Selling General Administrative of 31.2 M, as well as many indicators such as Price To Sales Ratio of 9.78, Dividend Yield of 0.0985 or PTB Ratio of 1.53. Sabra financial statements analysis is a perfect complement when working with Sabra Healthcare Valuation or Volatility modules.
  
Build AI portfolio with Sabra Stock
Check out the analysis of Sabra Healthcare Correlation against competitors.

Sabra Healthcare Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.3 B6.1 B4 B
Slightly volatile
Short and Long Term Debt Total2.2 B2.8 B2.1 B
Slightly volatile
Total Current Liabilities271 M258.1 M128.5 M
Slightly volatile
Total Stockholder Equity2.2 B3.2 B2.1 B
Slightly volatile
Other Liabilities47.8 M40.4 M49 M
Very volatile
Property Plant And Equipment Net3.2 B5.3 B3.2 B
Slightly volatile
Net Debt1.9 B2.7 B1.8 B
Slightly volatile
Accounts Payable74 M78 M68.3 M
Slightly volatile
Cash86 M69.5 M78.1 M
Very volatile
Non Current Assets Total3.9 B5.9 B3.7 B
Slightly volatile
Other Assets423.2 M445.4 M1.1 B
Pretty Stable
Long Term Debt2.8 B2.7 B1.1 B
Slightly volatile
Cash And Short Term Investments86 M69.5 M78.1 M
Very volatile
Common Stock Total Equity2.8 M2.7 M1.5 M
Slightly volatile
Common Stock Shares Outstanding139.7 M271.5 M136.2 M
Slightly volatile
Short Term Investments20.7 M21.8 M63 M
Slightly volatile
Liabilities And Stockholders Equity4.3 B6.1 B4 B
Slightly volatile
Non Current Liabilities Total2 B2.7 B1.9 B
Slightly volatile
Other Stockholder Equity2.9 B5.3 B2.8 B
Slightly volatile
Total Liabilities2.1 B2.9 B2 B
Slightly volatile
Property Plant And Equipment Gross627.4 M757.1 M652 M
Slightly volatile
Total Current Assets340.8 M227.8 M306.8 M
Pretty Stable
Common Stock1.5 M2.7 M1.4 M
Slightly volatile
Intangible Assets57.4 M31.6 M48.4 M
Slightly volatile
Net Tangible Assets2.4 B3.5 B2.1 B
Slightly volatile
Net Receivables227.6 M151.5 M182 M
Slightly volatile
Long Term Debt Total2.8 B2.7 B1.2 B
Slightly volatile
Capital Surpluse2.9 B5.2 B2.7 B
Slightly volatile
Short Term Debt116.4 M122.5 M409 M
Very volatile
Long Term Investments169.8 M210.4 M126.1 M
Slightly volatile
Short and Long Term Debt91.1 M95.9 M753.9 M
Slightly volatile
Capital Lease Obligations46.1 M24.2 M71.6 M
Slightly volatile
Net Invested Capital4.7 B4.6 B6.1 B
Slightly volatile
Non Current Liabilities Other49.6 M29.3 M72.4 M
Slightly volatile
Net Working Capital255.7 M319.6 M480.6 M
Slightly volatile
Capital Stock2.4 M2.7 M2 M
Slightly volatile

Sabra Healthcare Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization134.9 M195.1 M127.6 M
Slightly volatile
Selling General Administrative31.2 M57.6 M30.3 M
Slightly volatile
Total Revenue429.4 M808.7 M417.2 M
Slightly volatile
Gross Profit352.6 M547.6 M335.8 M
Slightly volatile
Other Operating Expenses538.8 M513.1 M254.7 M
Slightly volatile
Operating Income206.7 M295.6 M195.3 M
Slightly volatile
EBITDA276.5 M474.5 M266 M
Slightly volatile
Total Operating Expenses163.9 M252 M155.9 M
Slightly volatile
Cost Of Revenue274.2 M261.2 M100.1 M
Slightly volatile
Net Income From Continuing Ops80.9 M114 M91.1 M
Pretty Stable
Preferred Stock And Other Adjustments10.8 M11.2 M9.6 M
Slightly volatile
Tax Provision1.7 M1.2 M1.3 M
Slightly volatile
Reconciled Depreciation191.1 M195.1 M151 M
Slightly volatile
Interest Income6.7 M7.8 M6.1 M
Slightly volatile

Sabra Healthcare Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation8.1 M10.3 M7.6 M
Slightly volatile
Depreciation121.6 M195.1 M116.2 M
Slightly volatile
Total Cash From Operating Activities224.1 M357.1 M213.9 M
Slightly volatile
End Period Cash Flow88.6 M76.3 M80.8 M
Very volatile
Begin Period Cash Flow95.2 M53.7 M84.4 M
Very volatile
Issuance Of Capital Stock73.6 M77.5 M242 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio9.786.618.809
Slightly volatile
Dividend Yield0.09850.07970.0894
Pretty Stable
PTB Ratio1.531.71.4193
Slightly volatile
Days Sales Outstanding74.7178.64159
Slightly volatile
Book Value Per Share12.2510.5714.8539
Very volatile
Operating Cash Flow Per Share1.281.21.559
Very volatile
Stock Based Compensation To Revenue0.0140.01470.0292
Slightly volatile
Capex To Depreciation0.210.222.116
Slightly volatile
PB Ratio1.531.71.4193
Slightly volatile
EV To Sales17.1810.5115.4148
Slightly volatile
Payables Turnover0.490.470.3309
Slightly volatile
Sales General And Administrative To Revenue0.110.08190.0981
Slightly volatile
Capex To Revenue0.06450.06790.6276
Slightly volatile
Cash Per Share0.280.30.8402
Slightly volatile
POCF Ratio16.8414.9815.383
Slightly volatile
Interest Coverage1.822.012.1732
Pretty Stable
Capex To Operating Cash Flow0.10.111.5065
Slightly volatile
Days Payables Outstanding7638031.8 K
Slightly volatile
EV To Operating Cash Flow30.0423.8127.2625
Slightly volatile
Intangibles To Total Assets0.00570.0060.0114
Slightly volatile
Net Debt To EBITDA12.716.6411.3258
Slightly volatile
Current Ratio0.961.013.8677
Slightly volatile
Tangible Book Value Per Share12.0210.4614.5789
Very volatile
Receivables Turnover2.714.84.0325
Pretty Stable
Graham Number12.8210.7814.1157
Pretty Stable
Shareholders Equity Per Share12.2510.5714.85
Very volatile
Debt To Equity1.251.031.1425
Slightly volatile
Capex Per Share0.170.182.0633
Slightly volatile
Revenue Per Share2.462.713.024
Very volatile
Interest Debt Per Share18.7712.6116.897
Slightly volatile
Debt To Assets0.550.530.5068
Slightly volatile
Enterprise Value Over EBITDA29.5817.9226.5205
Slightly volatile
Short Term Coverage Ratios3.183.3538.1652
Slightly volatile
Operating Cycle74.7178.64159
Slightly volatile
Price Book Value Ratio1.531.71.4193
Slightly volatile
Days Of Payables Outstanding7638031.8 K
Slightly volatile
Price To Operating Cash Flows Ratio16.8414.9815.383
Slightly volatile
Operating Profit Margin0.540.420.4782
Very volatile
Company Equity Multiplier2.432.222.224
Slightly volatile
Long Term Debt To Capitalization0.560.530.5168
Slightly volatile
Total Debt To Capitalization0.570.540.5223
Slightly volatile
Return On Capital Employed0.04120.04550.0497
Very volatile
Debt Equity Ratio1.251.031.1425
Slightly volatile
Ebit Per Revenue0.540.420.4782
Very volatile
Quick Ratio0.961.013.8677
Slightly volatile
Dividend Paid And Capex Coverage Ratio0.741.00.9134
Slightly volatile
Net Income Per E B T1.081.143.1145
Slightly volatile
Cash Ratio0.290.310.9208
Slightly volatile
Operating Cash Flow Sales Ratio0.590.510.537
Pretty Stable
Days Of Sales Outstanding74.7178.64159
Slightly volatile
Cash Flow Coverage Ratios0.0880.110.1057
Slightly volatile
Price To Book Ratio1.531.71.4193
Slightly volatile
Fixed Asset Turnover67.964.6633.2116
Slightly volatile
Capital Expenditure Coverage Ratio10.029.544.4338
Slightly volatile
Price Cash Flow Ratio16.8414.9815.383
Slightly volatile
Enterprise Value Multiple29.5817.9226.5205
Slightly volatile
Debt Ratio0.550.530.5068
Slightly volatile
Cash Flow To Debt Ratio0.0880.110.1057
Slightly volatile
Price Sales Ratio9.786.618.809
Slightly volatile
Asset Turnover0.07840.120.0982
Slightly volatile
Gross Profit Margin0.940.780.8789
Slightly volatile
Price Fair Value1.531.71.4193
Slightly volatile

Sabra Healthcare Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.6 B3 B2.1 B
Slightly volatile
Enterprise Value3.2 B5.1 B3.9 B
Slightly volatile

Sabra Fundamental Market Drivers

Forward Price Earnings8.7108
Cash And Short Term Investments60.5 M

Sabra Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Sabra Healthcare Financial Statements

Sabra Healthcare stakeholders use historical fundamental indicators, such as Sabra Healthcare's revenue or net income, to determine how well the company is positioned to perform in the future. Although Sabra Healthcare investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sabra Healthcare's assets and liabilities are reflected in the revenues and expenses on Sabra Healthcare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sabra Healthcare REIT. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-84.9 M-89.1 M
Total Revenue808.7 M429.4 M
Cost Of Revenue261.2 M274.2 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.08  0.11 
Capex To Revenue 0.07  0.06 
Revenue Per Share 2.71  2.46 
Ebit Per Revenue 0.42  0.54 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
HITIHigh Tide
HITIHigh Tide
BACBank of America
When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:
How To Invest In Sabra
Details
Is Sabra Stock a good investment?
Details
What is Sabra Healthcare's Net Worth?
Details
Largest Diversified REITs Companies
View
Largest Equity Real Estate Investment Trusts (REITs) Companies
View
Check out the analysis of Sabra Healthcare Correlation against competitors.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.29)
Dividend Share
1.2
Earnings Share
0.73
Revenue Per Share
3.138
Quarterly Revenue Growth
0.073
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY